Skip to main content
. Author manuscript; available in PMC: 2016 Nov 3.
Published in final edited form as: J Neuropathol Exp Neurol. 2015 Sep;74(9):873–888. doi: 10.1097/NEN.0000000000000228

Figure 1.

Figure 1

The numbers of female (red) and male (blue) patients with Prion-only, Prion-Alzheimer disease (Prion-AD), and AD-only are plotted as a function of the age of death. (A) The ages of death for the Prion-only group shows a predominance of males from 30 to 59 years of age, a predominance of females from ages of 60 to 74, and a predominance of males from 75 to 84 years. (B) The Prion-AD group has a noticeable predominance of females especially from the age of 65 to 70 and age 80. (C) Adding the number of females and males from the Prion-only group to the numbers in the Prion-AD group brings the ratio of females to males to near 1:1. Females predominate between the ages of 60 and 69 and between ages 80 to 84. Males tend to predominate at the younger ages, from 30 to 59. (D) In the AD-only group, females predominate at almost all ages.